Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
4
×
clinical trials
life sciences
national blog main
allergan
boston blog main
boston top stories
eli lilly
fda
national top stories
deals
europe blog main
merck
national
new york blog main
san francisco blog main
4d molecular therapeutics
acne
agenus
alkermes
alzheimer's disease
amgen
astrazeneca
auris health
avexis
bayer
biohaven
biomx
bladder cancer
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
buprenorphine
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
What
treatment
4
×
fda
approved
drug
medicines
abbvie
adults
alkermes
allergan
alliance
antipsychotic
benefits
bio
biotech
caveats
class
commonly
companies
designed
digital
disease
editas
editing
effect
epidemic
exits
experimental
fatty
favor
frenzied
gain
gene
genetic
growing
known
led
liver
medicine
merck
migraine
Language
unset
Current search:
abbvie
×
biotech
×
treatment
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More